Moving Beyond Solid Tumors: A Novel Radiotherapy in Hematologic Cancers

Time: 2:00 pm
day: Day One

Details:

  • Understanding Phospholipid ethers (PLE)s as a novel radioconjungate platform
    (PRCs)
  • Review of Bexxar and Zevalin in hematologic cancers: Successes and challenges
  • Highlights of PRCs data and methods to overcome challenges

Speakers: